MedPath

Effect of Sacubitril-Valsartan versus angiotensin-converting enzyme inhibitors (ACEI) and angiotensin receptor blocker (ARB) on left ventricular ejection fraction in patient with heart failure

Phase 3
Recruiting
Conditions
Heart failure.
Heart failure
Registration Number
IRCT20120215009014N503
Lead Sponsor
Hamedan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
225
Inclusion Criteria

Age 18 to 80 years
Heart failure

Exclusion Criteria

Severe coronary disease
Valvular heart disease
Pulmonary thromboembolism
Congenital heart disease

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.